We demonstrated previously that metformin suppresses the production of insulin-resistance-inducing SeP by activating AMPK and, subsequently, inactivating FoxO3a in the liver without directly stimulating pancreatic β-cells [17]. The gene discussed is FOXO3; the disease is Insulin resistance.